(Updated - July 20, 2015 9:09 AM EDT)

Goldman Sachs upgraded FibroGen (NASDAQ: FGEN) from Neutral to Buy with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE